Format:
1 Online-Ressource
ISSN:
1758-2652
Content:
Purpose of the study: To compare the lipometabolic profiles of three double-boosted protease inhibitor (PI) regimens at standard dose, containing saquinavir and ritonavir in combination with lopinavir (LOPSAQ), atazanavir (ATSAQ) or fosamprenavir (FOSAQ) in HIV-positive patients, treated without reverse transcriptase inhibitors (RTI). ...
Note:
From Ninth International Congress on Drug Therapy in HIV Infection Glasgow, UK, 9-13 November 2008
In:
International AIDS Society, Journal of the International AIDS Society, Berlin ; Heidelberg : Springer, 2004-, Band 11 (10. November 2008), Supplement 1, Artikel-ID: P122, 1758-2652
In:
volume:11
In:
year:2008
In:
day:10
In:
month:11
In:
supplement:Supplement 1
In:
extent:2
In:
elocationid:P122
Language:
English
DOI:
10.1186/1758-2652-11-S1-P122
URN:
urn:nbn:de:hebis:30-70666
Bookmarklink